Vireo Growth (VREOF) Short-term Investments (2020 - 2026)
Vireo Growth (VREOF) posted Short-term Investments of $15.4 million for Q1 2026, down 24.14% sequentially from $20.3 million in Q4 2025, and up 779.04% YoY from $1.8 million in Q1 2025.
Vireo Growth (VREOF) Short-term Investments (2020 - 2026) Analysis & Trends
Vireo Growth has reported Short-term Investments for 5 years, with the latest figure at $15.4 million in Q1 2026.
- Quarterly Short-term Investments rose 779.04% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.4 million (up 779.04% YoY) and the FY2025 annual result came in at $20.3 million, up 793.89% from the prior year.
- Short-term Investments eased to $15.4 million in Q1 2026 per VREOF's latest filing, from $20.3 million in the prior quarter.
- Over five years, Short-term Investments peaked at $20.3 million in Q4 2025 and troughed at $1.0 million in Q3 2025.
- A 4-year average of $6.3 million and a median of $1.9 million in 2023 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2024 and 2025: Short-term Investments rose 17.22% in 2024, then surged 793.89% in 2025.
- Over 4 years, Short-term Investments stood at $1.9 million in 2023, then grew by 17.22% to $2.3 million in 2024, then soared by 793.89% to $20.3 million in 2025, then declined by 24.14% to $15.4 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $15.4 million, $20.3 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Vireo Growth | 487.39 Mn | 345.09 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.40 Mn |
| Dec 31, 2025 | 20.30 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Dec 31, 2020 | 1.59 Mn |